Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Orkambi (lumacaftor/ivacaftor) for the Treatment of Cystic Fibrosis (CF)

Drug (Brand/Generic)

Orkambi (lumacaftor/ivacaftor)

Company / Licensee

Vertex Pharmaceuticals

Product Description

Cystic fibrosis transmembrane conductance regulator

Current Indication

Cystic fibrosis

Market Sector

Respiratory

Development Status

Approved in the US
Expand

Go Top